- Evaluate your small molecule, biologic, or formulation excipients for its potential to lyse red blood cells
- Personalized experimental design to ensure the most relevant data is obtained with the options to examine all relevant in vivo pharmacologically relevant blood from appropriate species
- All assays are performed with high-quality reagents and strict controls by experienced immunologists
Service Overview
About the Hemolysis Assay
We measure in vitro hemolysis by evaluating hemoglobin release as a marker of red blood cell lysis following test agent exposure. Exposure to drugs (biologics or excipients) can cause hemolysis, even in normal adults, potentially resulting in neutropenia, thrombocytopenia, hemolytic anemia, aplastic anemia, and macrocytic anemia. Therefore, according to FDA recommendations, testing for hemolytic potential should be performed.